Risk factors for diabetic retinopathy

Czech version

Authors: T. Sosna ^1,2; R. Švancarová ¹; M. Netuková ³
Authors‘ workplace: Centrum diabetologie IKEM Praha, přednostka prof. MUDr. Terezie Pelikánová, DrSc. ¹; Oční oddělení Thomayerovy nemocnice Praha, primář MUDr. Karel Sedláček ²; Oftalmologická klinika 3. lékařské fakulty UK a FN Královské Vinohrady Praha, přednosta prof. MUDr. Pavel Kuchynka, CSc. ³
Published in: Vnitř Lék 2013; 59(3): 177-181
Category: Reviews

Overview

Risk factors for diabetic retinopathy can be divided into modifiable and non modifiable. Non modifiable include the type of diabetes, age of the patient at the time of onset, duration, and genetic factors. Primarily it can be influenced by glycemic control, as well as systemic factors such as blood pressure, serum lipids. Concomitant diseases also affect diabetic retinopathy. The article also mentions the risk of rapid compensation and iatrogenic influences.

Key words:
diabetic retinopathy – risk factors – glycosylated hemoglobin – hypertension – dyslipidemia

Sources

1. ACCORD Study Group; ACCORD Eye Study Group. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010; 363: 233–244.

2. Aiello LP, Gardner TW, King GL et al. Diabetic Retinopathy. Diabetes Care 1998; 21:143–156.

3. Doodson MP. Diabetic Retinopathy. Oxford University Press 2008, 172 s.

4. Easty DL, Sparrow JM. Oxford textbook of ophthalmology. New York: Oxford University Press 1999, 1308 s.

5. FIELD study investigators. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet. 2007; 370: 1687–1697.

6. Chantelau E, Eggert H. Acceleration of diabetic retinopathy following improved glycaemic control: a report on 13 cases. Abstract. Diabetologia 1997; 40: (Suppl. 1): A501.

7. Klein R, Klein BEK, Moss SE et al. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med 1989; 149: 2427–2432.

8. Klein R, Klein BEK, Moss. SE The Wisconsin epidemiological study of diabetic retinopathy: a review. Diabet Metab Rev 1989; 5: 559–570.

9. Kuchyňka P et al. Oční lékařství. Praha: Grada 2007, 768 s.

10. Marshall G, Garg SK, Jackson WE et al. Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin--dependent diabetes mellitus. Ophthalmology 1993; 100: 1133–1139.

11. Murphy RP. Management of diabetic retinopathy. Am Fam Physician 1995; 51: 785–796.

12. Pelikánová T, Bartoš V. Praktická diabetologie. Praha: Maxdorf 2010, 738 s.

13. Pickup J, Williams G. Textbook of diabetes. Oxford: Blackwell Science Ltd. 1997.

14. Ryan J. Retina. St. Louise: Mosby Inc. 2001, 1847 s.

15. Scanlon P, Aldington S, Wilkinson Ch et al. Practical Manual of Diabetic Retinopathy Management Wiley-Blackwel 2009, 232 s.

16. Sosna T, Bouček P, Fišer I. Diabetická retinopatie – diagnostika, prevence, léčba. Praha: J. Cendelín 2001, 255 s.

17. The EURODIAB IDDM Complications Study. Retinopathy and vision loss on insulin-dependent diabetes in Europe. Ophthalmology 1997; 104: 252–260.

18. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive bloodglucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854–865.